Copyright
©The Author(s) 2017.
World J Hepatol. Jul 8, 2017; 9(19): 857-866
Published online Jul 8, 2017. doi: 10.4254/wjh.v9.i19.857
Published online Jul 8, 2017. doi: 10.4254/wjh.v9.i19.857
No/one criterion for hepatic steatosis | US+ and ALT+ | P-value | |
n = 1106 | n = 192 | ||
Age (yr), M (SD) | 59.6 (8.8) | 57.2 (7.8) | P < 0.01 |
Male gender | 442 (40.0) | 139 (72.4) | P < 0.001 |
School education | n.s. | ||
< 10 yr | 570 (51.5) | 102 (53.1) | |
10 yr | 358 (32.4) | 67 (34.9) | |
> 10 yr | 178 (16.1) | 23 (12.0) | |
Waist circumference (cm), M (SD) | 89.0 (11.5) | 100.8 (10.9) | P < 0.001 |
Body weight (kg), M (SD) | 75.6 (12.8) | 88.6 (13.9) | P < 0.001 |
BMI, (kg/m2), M (SD) | 27.4 (4.3) | 30.5 (4.6) | P < 0.001 |
Smoking | P < 0.001 | ||
Never-smoker | 516 (46.6) | 57 (29.7) | |
Ex-smoker | 382 (34.5) | 99 (51.7) | |
Current smoker | 208 (18.8) | 36 (18.8) | |
Alcohol consumption (g/d), M (SD) | 9.1 (14.5) | 15.6 (19.5) | P < 0.001 |
Diabetes mellitus | 100 (9.0) | 26 (13.5) | P < 0.001 |
Systolic blood pressure (mmHg), M (SD) | 139.3 (20.2) | 148.5 (17.4) | P < 0.001 |
Diastolic blood pressure (mmHg), M (SD) | 84.7 (10.8) | 89.9 (10.4) | P < 0.001 |
Pulse pressure (mmHg), M (SD) | 54.6 (14.7) | 58.6 (13.4) | P < 0.01 |
Hypertension | 660 (59.7) | 163 (84.9) | P < 0.001 |
Intake of drugs with ATC07 | 239 (21.6) | 39 (20.3) | n.s. |
Intake of drugs with ATC08 | 140 (12.7) | 28 (14.6) | n.s. |
Intake of drugs with ATC09 | 198 (17.9) | 58 (30.2) | P < 0.001 |
IVS, M (SD) | 9.7 (2.2) | 10.9 (2.5) | P < 0.001 |
LVEDD, M (SD) | 50.9 (5.6) | 52.4 (5.9) | P < 0.01 |
PWD, M (SD) | 9.6 (1.9) | 10.4 (2.0) | P < 0.001 |
LVM (g), M (SD) | 181.8 (53.5) | 215.8 (61.3) | P < 0.001 |
LVMI (g/m2.7), M (SD) | 46.2 (13.3) | 51.0 (13.7) | P < 0.001 |
LVH | 499 (45.1) | 114 (59.4) | P < 0.001 |
Baseline | Follow-up | P-value | |
M (SD) | M (SD) | ||
IVS, M (SD) | |||
No/one criterion for hepatic steatosis | 9.7 (2.2) | 11.2 (2.7) | P < 0.001 |
US+ and ALT+ | 10.9 (2.5) | 12.0 (2.9) | P < 0.001 |
LVEDD, M (SD) | |||
No/one criterion for hepatic steatosis | 50.9 (5.6) | 48.8 (5.5) | P < 0.001 |
US+ and ALT+ | 52.4 (5.9) | 50.6 (5.3) | P < 0.001 |
PWD, M (SD) | |||
No/one criterion for hepatic steatosis | 9.6 (1.9) | 9.9 (1.9) | P < 0.001 |
US+ and ALT+ | 10.4 (2.0) | 10.9 (2.1) | P < 0.01 |
LVM (g), M (SD) | |||
No/one criterion for hepatic steatosis | 181.8 (53.5) | 192.2 (56.8) | P < 0.001 |
US+ and ALT+ | 215.8 (61.3) | 226.1 (62.4) | P < 0.01 |
LVMI (g/m2.7), M(SD) | |||
No/one criterion for hepatic steatosis | 46.2 (13.3) | 49.2 (14.6) | P < 0.001 |
US+ and ALT+ | 51.0 (13.7) | 53.7 (14.4) | P < 0.01 |
SBP (mmHg), M (SD) | |||
No/one criterion for hepatic steatosis | 139.3 (20.2) | 136.3 (19.2) | P < 0.001 |
US+ and ALT+ | 148.5 (17.4) | 142.8 (19.0) | P < 0.001 |
DBP (mmHg), M (SD) | |||
No/one criterion for hepatic steatosis | 84.7 (10.8) | 81.2 (10.3) | P < 0.001 |
US+ and ALT+ | 89.9 (10.4) | 85.0 (11.1) | P < 0.001 |
LVH | |||
No/one criterion for hepatic steatosis | 499 (45.1) | 597 (54.0) | P < 0.001 |
US+ and ALT+ | 114 (59.4) | 128 (66.7) | P < 0.001 |
Hypertension | |||
No/one criterion for hepatic steatosis | 660 (59.7) | 686 (62.0) | P < 0.001 |
US+ and ALT+ | 163 (84.9) | 154 (80.2) | P < 0.001 |
- Citation: Piontek K, Schmidt CO, Baumeister SE, Lerch MM, Mayerle J, Dörr M, Felix SB, Völzke H. Is hepatic steatosis associated with left ventricular mass index increase in the general population? World J Hepatol 2017; 9(19): 857-866
- URL: https://www.wjgnet.com/1948-5182/full/v9/i19/857.htm
- DOI: https://dx.doi.org/10.4254/wjh.v9.i19.857